カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のペラミビル市場2022年：溶液、固溶体

◆英語タイトル：Global Peramivir Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8930 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：108 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ペラミビル市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のペラミビルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ペラミビル市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・溶液、固溶体

用途別セグメントは次のように区分されます。
・インフルエンザA型治療、インフルエンザB型治療

世界のペラミビル市場の主要な市場プレーヤーは以下のとおりです。
・BioCryst Pharmaceuticals、Green Cross Pharma、Shionogi Co.、NeoPharm、Moksha8 Pharma、NT Pharma、Merck、Hikma Pharmaceuticals、Hunan Nucien Pharmaceutical Co., Ltd.、SCOLR Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ペラミビル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なペラミビルメーカーの企業概要、2019年～2022年までのペラミビルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なペラミビルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ペラミビルの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのペラミビルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのペラミビル市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびペラミビルの産業チェーンを掲載しています。
・第13、14、15章では、ペラミビルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：BioCryst Pharmaceuticals、Green Cross Pharma、Shionogi Co.、NeoPharm、Moksha8 Pharma、NT Pharma、Merck、Hikma Pharmaceuticals、Hunan Nucien Pharmaceutical Co., Ltd.、SCOLR Pharma
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：溶液、固溶体
・用途別分析2017年-2028年：インフルエンザA型治療、インフルエンザB型治療
・ペラミビルの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ペラミビルのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ペラミビルのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ペラミビルの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ペラミビルの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Peramivir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Peramivir market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Influenza A Treatment accounting for % of the Peramivir global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Solution segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, and Moksha8 Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Peramivir market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Solution
Solid
Market segment by Application can be divided into
Influenza A Treatment
Influenza B Treatment
The key market players for global Peramivir market are listed below:
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peramivir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peramivir, with price, sales, revenue and global market share of Peramivir from 2019 to 2022.
Chapter 3, the Peramivir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peramivir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Peramivir market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Peramivir.
Chapter 13, 14, and 15, to describe Peramivir sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Peramivir Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peramivir Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Solution
1.2.3 Solid
1.3 Market Analysis by Application
1.3.1 Overview: Global Peramivir Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Global Peramivir Market Size & Forecast
1.4.1 Global Peramivir Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Peramivir Sales in Volume (2017-2028)
1.4.3 Global Peramivir Price (2017-2028)
1.5 Global Peramivir Production Capacity Analysis
1.5.1 Global Peramivir Total Production Capacity (2017-2028)
1.5.2 Global Peramivir Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Peramivir Market Drivers
1.6.2 Peramivir Market Restraints
1.6.3 Peramivir Trends Analysis
2 Manufacturers Profiles
2.1 BioCryst Pharmaceuticals
2.1.1 BioCryst Pharmaceuticals Details
2.1.2 BioCryst Pharmaceuticals Major Business
2.1.3 BioCryst Pharmaceuticals Peramivir Product and Services
2.1.4 BioCryst Pharmaceuticals Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Green Cross Pharma
2.2.1 Green Cross Pharma Details
2.2.2 Green Cross Pharma Major Business
2.2.3 Green Cross Pharma Peramivir Product and Services
2.2.4 Green Cross Pharma Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Shionogi Co.
2.3.1 Shionogi Co. Details
2.3.2 Shionogi Co. Major Business
2.3.3 Shionogi Co. Peramivir Product and Services
2.3.4 Shionogi Co. Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 NeoPharm
2.4.1 NeoPharm Details
2.4.2 NeoPharm Major Business
2.4.3 NeoPharm Peramivir Product and Services
2.4.4 NeoPharm Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Moksha8 Pharma
2.5.1 Moksha8 Pharma Details
2.5.2 Moksha8 Pharma Major Business
2.5.3 Moksha8 Pharma Peramivir Product and Services
2.5.4 Moksha8 Pharma Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 NT Pharma
2.6.1 NT Pharma Details
2.6.2 NT Pharma Major Business
2.6.3 NT Pharma Peramivir Product and Services
2.6.4 NT Pharma Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Peramivir Product and Services
2.7.4 Merck Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hikma Pharmaceuticals
2.8.1 Hikma Pharmaceuticals Details
2.8.2 Hikma Pharmaceuticals Major Business
2.8.3 Hikma Pharmaceuticals Peramivir Product and Services
2.8.4 Hikma Pharmaceuticals Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hunan Nucien Pharmaceutical Co., Ltd.
2.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Details
2.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Major Business
2.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product and Services
2.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 SCOLR Pharma
2.10.1 SCOLR Pharma Details
2.10.2 SCOLR Pharma Major Business
2.10.3 SCOLR Pharma Peramivir Product and Services
2.10.4 SCOLR Pharma Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Peramivir Breakdown Data by Manufacturer
3.1 Global Peramivir Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Peramivir Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Peramivir
3.4 Market Concentration Rate
3.4.1 Top 3 Peramivir Manufacturer Market Share in 2021
3.4.2 Top 6 Peramivir Manufacturer Market Share in 2021
3.5 Global Peramivir Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Peramivir Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Peramivir Market Size by Region
4.1.1 Global Peramivir Sales in Volume by Region (2017-2028)
4.1.2 Global Peramivir Revenue by Region (2017-2028)
4.2 North America Peramivir Revenue (2017-2028)
4.3 Europe Peramivir Revenue (2017-2028)
4.4 Asia-Pacific Peramivir Revenue (2017-2028)
4.5 South America Peramivir Revenue (2017-2028)
4.6 Middle East and Africa Peramivir Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Peramivir Sales in Volume by Type (2017-2028)
5.2 Global Peramivir Revenue by Type (2017-2028)
5.3 Global Peramivir Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Peramivir Sales in Volume by Application (2017-2028)
6.2 Global Peramivir Revenue by Application (2017-2028)
6.3 Global Peramivir Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Peramivir Sales by Type (2017-2028)
7.2 North America Peramivir Sales by Application (2017-2028)
7.3 North America Peramivir Market Size by Country
7.3.1 North America Peramivir Sales in Volume by Country (2017-2028)
7.3.2 North America Peramivir Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Peramivir Sales by Type (2017-2028)
8.2 Europe Peramivir Sales by Application (2017-2028)
8.3 Europe Peramivir Market Size by Country
8.3.1 Europe Peramivir Sales in Volume by Country (2017-2028)
8.3.2 Europe Peramivir Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Peramivir Sales by Type (2017-2028)
9.2 Asia-Pacific Peramivir Sales by Application (2017-2028)
9.3 Asia-Pacific Peramivir Market Size by Region
9.3.1 Asia-Pacific Peramivir Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Peramivir Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Peramivir Sales by Type (2017-2028)
10.2 South America Peramivir Sales by Application (2017-2028)
10.3 South America Peramivir Market Size by Country
10.3.1 South America Peramivir Sales in Volume by Country (2017-2028)
10.3.2 South America Peramivir Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Peramivir Sales by Type (2017-2028)
11.2 Middle East & Africa Peramivir Sales by Application (2017-2028)
11.3 Middle East & Africa Peramivir Market Size by Country
11.3.1 Middle East & Africa Peramivir Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Peramivir Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Peramivir and Key Manufacturers
12.2 Manufacturing Costs Percentage of Peramivir
12.3 Peramivir Production Process
12.4 Peramivir Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Peramivir Typical Distributors
13.3 Peramivir Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Peramivir Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Peramivir Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. BioCryst Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. BioCryst Pharmaceuticals Major Business
Table 5. BioCryst Pharmaceuticals Peramivir Product and Services
Table 6. BioCryst Pharmaceuticals Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Green Cross Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Green Cross Pharma Major Business
Table 9. Green Cross Pharma Peramivir Product and Services
Table 10. Green Cross Pharma Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Shionogi Co. Basic Information, Manufacturing Base and Competitors
Table 12. Shionogi Co. Major Business
Table 13. Shionogi Co. Peramivir Product and Services
Table 14. Shionogi Co. Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. NeoPharm Basic Information, Manufacturing Base and Competitors
Table 16. NeoPharm Major Business
Table 17. NeoPharm Peramivir Product and Services
Table 18. NeoPharm Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Moksha8 Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Moksha8 Pharma Major Business
Table 21. Moksha8 Pharma Peramivir Product and Services
Table 22. Moksha8 Pharma Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. NT Pharma Basic Information, Manufacturing Base and Competitors
Table 24. NT Pharma Major Business
Table 25. NT Pharma Peramivir Product and Services
Table 26. NT Pharma Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Peramivir Product and Services
Table 30. Merck Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Hikma Pharmaceuticals Major Business
Table 33. Hikma Pharmaceuticals Peramivir Product and Services
Table 34. Hikma Pharmaceuticals Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Hunan Nucien Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. Hunan Nucien Pharmaceutical Co., Ltd. Major Business
Table 37. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product and Services
Table 38. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. SCOLR Pharma Basic Information, Manufacturing Base and Competitors
Table 40. SCOLR Pharma Major Business
Table 41. SCOLR Pharma Peramivir Product and Services
Table 42. SCOLR Pharma Peramivir Sales (Kilotons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Peramivir Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kilotons)
Table 44. Global Peramivir Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Peramivir, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Peramivir Production Capacity by Company, (Kilotons): 2020 VS 2021
Table 47. Head Office and Peramivir Production Site of Key Manufacturer
Table 48. Peramivir New Entrant and Capacity Expansion Plans
Table 49. Peramivir Mergers & Acquisitions in the Past Five Years
Table 50. Global Peramivir Sales by Region (2017-2022) & (Kilotons)
Table 51. Global Peramivir Sales by Region (2023-2028) & (Kilotons)
Table 52. Global Peramivir Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Peramivir Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 55. Global Peramivir Sales by Type (2023-2028) & (Kilotons)
Table 56. Global Peramivir Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Peramivir Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Peramivir Price by Type (2017-2022) & (US$/Kg)
Table 59. Global Peramivir Price by Type (2023-2028) & (US$/Kg)
Table 60. Global Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 61. Global Peramivir Sales by Application (2023-2028) & (Kilotons)
Table 62. Global Peramivir Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Peramivir Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Peramivir Price by Application (2017-2022) & (US$/Kg)
Table 65. Global Peramivir Price by Application (2023-2028) & (US$/Kg)
Table 66. North America Peramivir Sales by Country (2017-2022) & (Kilotons)
Table 67. North America Peramivir Sales by Country (2023-2028) & (Kilotons)
Table 68. North America Peramivir Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Peramivir Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 71. North America Peramivir Sales by Type (2023-2028) & (Kilotons)
Table 72. North America Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 73. North America Peramivir Sales by Application (2023-2028) & (Kilotons)
Table 74. Europe Peramivir Sales by Country (2017-2022) & (Kilotons)
Table 75. Europe Peramivir Sales by Country (2023-2028) & (Kilotons)
Table 76. Europe Peramivir Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Peramivir Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 79. Europe Peramivir Sales by Type (2023-2028) & (Kilotons)
Table 80. Europe Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 81. Europe Peramivir Sales by Application (2023-2028) & (Kilotons)
Table 82. Asia-Pacific Peramivir Sales by Region (2017-2022) & (Kilotons)
Table 83. Asia-Pacific Peramivir Sales by Region (2023-2028) & (Kilotons)
Table 84. Asia-Pacific Peramivir Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Peramivir Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 87. Asia-Pacific Peramivir Sales by Type (2023-2028) & (Kilotons)
Table 88. Asia-Pacific Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 89. Asia-Pacific Peramivir Sales by Application (2023-2028) & (Kilotons)
Table 90. South America Peramivir Sales by Country (2017-2022) & (Kilotons)
Table 91. South America Peramivir Sales by Country (2023-2028) & (Kilotons)
Table 92. South America Peramivir Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Peramivir Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 95. South America Peramivir Sales by Type (2023-2028) & (Kilotons)
Table 96. South America Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 97. South America Peramivir Sales by Application (2023-2028) & (Kilotons)
Table 98. Middle East & Africa Peramivir Sales by Region (2017-2022) & (Kilotons)
Table 99. Middle East & Africa Peramivir Sales by Region (2023-2028) & (Kilotons)
Table 100. Middle East & Africa Peramivir Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Peramivir Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 103. Middle East & Africa Peramivir Sales by Type (2023-2028) & (Kilotons)
Table 104. Middle East & Africa Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 105. Middle East & Africa Peramivir Sales by Application (2023-2028) & (Kilotons)
Table 106. Peramivir Raw Material
Table 107. Key Manufacturers of Peramivir Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Peramivir Typical Distributors
Table 111. Peramivir Typical Customers
List of Figures
Figure 1. Peramivir Picture
Figure 2. Global Peramivir Revenue Market Share by Type in 2021
Figure 3. Solution
Figure 4. Solid
Figure 5. Global Peramivir Revenue Market Share by Application in 2021
Figure 6. Influenza A Treatment
Figure 7. Influenza B Treatment
Figure 8. Global Peramivir Revenue, (USD Million) & (Kilotons): 2017 & 2021 & 2028
Figure 9. Global Peramivir Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Peramivir Sales (2017-2028) & (Kilotons)
Figure 11. Global Peramivir Price (2017-2028) & (US$/Kg)
Figure 12. Global Peramivir Production Capacity (2017-2028) & (Kilotons)
Figure 13. Global Peramivir Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Peramivir Market Drivers
Figure 15. Peramivir Market Restraints
Figure 16. Peramivir Market Trends
Figure 17. Global Peramivir Sales Market Share by Manufacturer in 2021
Figure 18. Global Peramivir Revenue Market Share by Manufacturer in 2021
Figure 19. Peramivir Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Peramivir Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Peramivir Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Peramivir Sales Market Share by Region (2017-2028)
Figure 23. Global Peramivir Revenue Market Share by Region (2017-2028)
Figure 24. North America Peramivir Revenue (2017-2028) & (USD Million)
Figure 25. Europe Peramivir Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Peramivir Revenue (2017-2028) & (USD Million)
Figure 27. South America Peramivir Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Peramivir Revenue (2017-2028) & (USD Million)
Figure 29. Global Peramivir Sales Market Share by Type (2017-2028)
Figure 30. Global Peramivir Revenue Market Share by Type (2017-2028)
Figure 31. Global Peramivir Price by Type (2017-2028) & (US$/Kg)
Figure 32. Global Peramivir Sales Market Share by Application (2017-2028)
Figure 33. Global Peramivir Revenue Market Share by Application (2017-2028)
Figure 34. Global Peramivir Price by Application (2017-2028) & (US$/Kg)
Figure 35. North America Peramivir Sales Market Share by Type (2017-2028)
Figure 36. North America Peramivir Sales Market Share by Application (2017-2028)
Figure 37. North America Peramivir Sales Market Share by Country (2017-2028)
Figure 38. North America Peramivir Revenue Market Share by Country (2017-2028)
Figure 39. United States Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Peramivir Sales Market Share by Type (2017-2028)
Figure 43. Europe Peramivir Sales Market Share by Application (2017-2028)
Figure 44. Europe Peramivir Sales Market Share by Country (2017-2028)
Figure 45. Europe Peramivir Revenue Market Share by Country (2017-2028)
Figure 46. Germany Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Peramivir Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Peramivir Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Peramivir Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Peramivir Revenue Market Share by Region (2017-2028)
Figure 55. China Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Peramivir Sales Market Share by Type (2017-2028)
Figure 62. South America Peramivir Sales Market Share by Application (2017-2028)
Figure 63. South America Peramivir Sales Market Share by Country (2017-2028)
Figure 64. South America Peramivir Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Peramivir Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Peramivir Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Peramivir Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Peramivir Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Peramivir Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Peramivir in 2021
Figure 76. Manufacturing Process Analysis of Peramivir
Figure 77. Peramivir Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のペラミビル市場2022年：溶液、固溶体(Global Peramivir Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のペラミビル市場2022年：溶液、固溶体

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp